News from united therapeutics corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 24, 2014, 11:26 ET

United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval...

Dec 17, 2014, 06:00 ET

United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change

 United Therapeutics Corporation (NASDAQ: UTHR) announced today two senior executive promotions as well as changes to Martine Rothblatt, Ph.D's...

Nov 13, 2014, 06:00 ET

Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors

United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Professor Katherine J. Klein, Ph.D., of The Wharton School of the...

Oct 28, 2014, 06:00 ET

United Therapeutics Corporation Reports Third Quarter 2014 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2014. "We...

Oct 21, 2014, 06:00 ET

United Therapeutics Corporation To Announce Third Quarter 2014 Financial Results Before Market Open On Tuesday, October 28, 2014

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2014 financial results before market...

Aug 29, 2014, 12:49 ET

District Court Decision Received In Remodulin Patent Case

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. District Court for the District of New Jersey has ruled in its...

Jul 29, 2014, 06:00 ET

United Therapeutics Corporation Reports Second Quarter 2014 Financial Results

 United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2014. "Our...

Jul 22, 2014, 06:00 ET

United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2014 financial results before market...

Jun 27, 2014, 06:00 ET

United Therapeutics Announces Additional $500 Million Share Repurchase Program

 United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to an additional...

May 06, 2014, 06:00 ET
Apr 29, 2014, 06:00 ET

United Therapeutics Corporation Reports First Quarter 2014 Financial Results

- Revenues of $289.4 million - Net income of $137.5 million - Earnings per Share of $2.73 per Basic Share or $2.43 per Diluted...

Apr 22, 2014, 06:00 ET

United Therapeutics Corporation To Announce First Quarter 2014 Financial Results Before Market Open On Tuesday, April 29, 2014

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2014 financial results before market...

Mar 26, 2014, 06:00 ET

Japan's Ministry of Health, Labour and Welfare Grants Approval for United Therapeutics' Remodulin

United Therapeutics Corporation (NASDAQ: UTHR) today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for...

Feb 25, 2014, 06:00 ET

United Therapeutics Corporation Reports 2013 Fourth Quarter And Annual Financial Results

  - Total Annual Revenues of $1.1 billion - Annual Earnings per Share of $3.49 per Basic Share or $3.28 per Diluted Share -...

Feb 18, 2014, 06:00 ET

United Therapeutics Corporation To Announce Fourth Quarter And Annual 2013 Financial Results Before Market Open On Tuesday, February 25, 2014

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2013 financial results...

Dec 20, 2013, 20:01 ET

FDA Approves Orenitram™ (treprostinil) Extended-Release Tablets for the Treatment of Pulmonary Arterial Hypertension

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved...

Dec 09, 2013, 06:00 ET

United Therapeutics Receives Subpoena From Office of Inspector General

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has received a subpoena from the Office of the Inspector General...

Oct 29, 2013, 06:00 ET

United Therapeutics Corporation Reports Third Quarter 2013 Financial Results

- Revenues of $302.2 million - Earnings per Share of $1.25 per Basic Share or $1.17 per Diluted Share - Non-GAAP Earnings of...

Oct 22, 2013, 06:00 ET

United Therapeutics Corporation to Announce Third Quarter 2013 Financial Results Before Market Open on Tuesday, October 29, 2013

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2013 financial results before market...

Sep 11, 2013, 17:00 ET

United Therapeutics Announces FDA Acceptance of Second Resubmission of Oral Treprostinil NDA

 United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. Food and Drug Administration (FDA) has...